MCS
The Marcus Corporation NYSE Listed Mar 17, 1980$18.26
Mkt Cap $564.8M
52w Low $12.85
75.5% of range
52w High $20.02
50d MA $17.57
200d MA $15.88
P/E (TTM)
42.9x
EV/EBITDA
8.7x
P/B
1.2x
Debt/Equity
0.7x
ROE
2.8%
P/FCF
482.5x
RSI (14)
—
ATR (14)
—
Beta
0.54
50d MA
$17.57
200d MA
$15.88
Avg Volume
146.0K
The Marcus Corporation, together with its subsidiaries, owns and operates movie theatres, and hotels and resorts in the United States. It operates in two segments, Theatres, and Hotels and Resorts. The Theatres segment operates multiscreen motion picture theatres, as well as Funset Boulevard, a family entertainment center. The Hotels and Resorts segment owns and operates full-service hotels and resorts, as well as manages full-service hotels, resorts, and other properties. The company also provides hospitality management services, including check-in, housekeeping, and maintenance for a vacation ownership development. As of December 30, 2021, it owned or operated 1,064 screens at 85 movie theatre locations in 17 states under the Marcus Theatres, Movie Tavern by Marcus, and BistroPlex brands; and operated 8 wholly-owned or majority-owned hotels and resorts, as well as managed 11 hotels, resorts, and other properties for third parties. The company was founded in 1935 and is headquartered in Milwaukee, Wisconsin.
100 East Wisconsin Avenue · Milwaukee, WI 53202-4125 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | BMO | -0.54 | -0.51 | +5.6% | 18.98 | -3.2% | -7.2% | -0.2% | -2.4% | +5.8% | -0.8% | — |
| Feb 26, 2026 | BMO | 0.07 | -0.06 | -185.7% | 15.88 | +5.2% | +3.4% | +2.5% | +0.1% | +2.1% | +1.7% | — |
| Oct 31, 2025 | BMO | 0.43 | 0.42 | -2.3% | 13.23 | +3.0% | +8.8% | +1.3% | +0.1% | +5.5% | -2.0% | — |
| Aug 1, 2025 | BMO | 0.19 | 0.23 | +21.1% | 16.37 | +3.7% | -9.2% | -0.5% | +0.8% | -1.2% | +2.5% | — |
| May 6, 2025 | BMO | -0.52 | -0.54 | -3.8% | 16.39 | -3.9% | -1.3% | +3.8% | +0.2% | +0.6% | +0.6% | — |
| Feb 27, 2025 | BMO | 0.04 | 0.13 | +225.0% | 20.87 | -2.2% | -11.2% | -1.1% | -3.6% | -2.5% | -1.7% | — |
| Oct 31, 2024 | BMO | 0.46 | 0.73 | +58.7% | 17.17 | +4.8% | +9.9% | +9.3% | +2.3% | +1.7% | +4.3% | — |
| Aug 1, 2024 | BMO | -0.01 | -0.17 | -2659.1% | 12.59 | -1.1% | +0.4% | +4.2% | -2.8% | +0.5% | -2.2% | — |
| May 2, 2024 | BMO | -0.37 | -0.38 | -2.7% | 13.11 | -1.8% | -8.1% | -1.2% | -5.4% | -0.3% | -0.6% | — |
| Feb 29, 2024 | BMO | -0.17 | -0.05 | +70.6% | 14.79 | -4.1% | -0.8% | -2.2% | +1.3% | -0.9% | -0.8% | — |
| Nov 1, 2023 | BMO | 0.34 | 0.31 | -8.8% | 15.54 | -3.0% | -1.5% | -0.1% | +1.8% | -0.8% | -1.1% | — |
| Aug 2, 2023 | BMO | 0.29 | 0.35 | +20.7% | 15.74 | +1.7% | +2.1% | +1.2% | +0.0% | +1.5% | -0.2% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30 | Wedbush | Maintains | Outperform → Outperform | — | $18.98 | $18.38 | -3.2% | -7.2% | -0.2% | -2.4% | +5.8% | -0.8% |
| Mar 2 | Barrington Research | Maintains | Outperform → Outperform | — | $16.83 | $16.73 | -0.6% | +0.1% | +2.1% | +1.7% | +0.5% | -1.3% |
| Jan 26 | Barrington Research | Maintains | Outperform → Outperform | — | $15.60 | $15.60 | +0.0% | -2.6% | +0.3% | -2.3% | +1.3% | +0.1% |
| Dec 12 | Barrington Research | Maintains | Outperform → Outperform | — | $16.01 | $16.17 | +1.0% | +0.7% | -1.2% | -1.6% | +0.1% | -1.3% |
| Nov 3 | Barrington Research | Maintains | Outperform → Outperform | — | $14.40 | $14.50 | +0.7% | +1.2% | +0.1% | +5.5% | -2.0% | -0.1% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $13.23 | $13.63 | +3.0% | +8.8% | +1.3% | +0.1% | +5.5% | -2.0% |
| Oct 6 | Benchmark | Maintains | Buy → Buy | — | $15.35 | $15.30 | -0.3% | -4.1% | -2.6% | -2.8% | -0.6% | -2.3% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $15.47 | $15.50 | +0.2% | +0.7% | +0.3% | -1.0% | +1.2% | -1.6% |
| Aug 4 | Barrington Research | Maintains | Outperform → Outperform | — | $14.87 | $15.14 | +1.8% | -0.5% | +0.8% | -1.2% | +2.5% | -3.2% |
| May 23 | Barrington Research | Maintains | Outperform → Outperform | — | $16.92 | $16.59 | -2.0% | +0.8% | +9.7% | +0.0% | -0.6% | -0.6% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $16.39 | $15.75 | -3.9% | -1.3% | +3.8% | +0.2% | +0.6% | +0.6% |
| Apr 15 | Barrington Research | Maintains | Outperform → Outperform | — | $16.21 | $16.26 | +0.3% | +0.3% | -1.6% | +1.2% | -1.3% | +1.8% |
| Apr 11 | Benchmark | Maintains | Buy → Buy | — | $15.98 | $16.06 | +0.5% | +0.1% | +1.4% | +0.3% | -1.6% | +1.2% |
| Mar 3 | Barrington Research | Maintains | Outperform → Outperform | — | $18.34 | $18.34 | +0.0% | -3.6% | -2.5% | -1.7% | -1.8% | -0.3% |
| Feb 27 | Barrington Research | Maintains | Outperform → Outperform | — | $20.87 | $20.41 | -2.2% | -11.2% | -1.1% | -3.6% | -2.5% | -1.7% |
| Jan 30 | Benchmark | Maintains | Buy → Buy | — | $20.80 | $20.92 | +0.6% | -2.0% | -1.3% | +2.1% | +0.5% | +4.0% |
| Nov 25 | Benchmark | Maintains | Buy → Buy | — | $22.03 | $22.37 | +1.5% | +0.3% | -0.8% | +2.6% | +0.7% | +2.3% |
| Nov 13 | Barrington Research | Maintains | Outperform → Outperform | — | $22.12 | $22.21 | +0.4% | -0.6% | +1.8% | -2.7% | -1.3% | +1.4% |
| Nov 4 | Barrington Research | Maintains | Outperform → Outperform | — | $20.62 | $20.81 | +0.9% | +2.3% | +1.7% | +4.3% | -1.8% | -0.6% |
| Nov 1 | Benchmark | Maintains | Buy → Buy | — | $18.87 | $19.44 | +3.0% | +9.3% | +2.3% | +1.7% | +4.3% | -1.8% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $17.17 | $18.00 | +4.8% | +9.9% | +9.3% | +2.3% | +1.7% | +4.3% |
| Oct 2 | Benchmark | Maintains | Buy → Buy | — | $15.15 | $15.46 | +2.0% | +6.2% | -1.1% | -0.5% | -2.4% | -0.8% |
| Sep 20 | Barrington Research | Maintains | Outperform → Outperform | — | $14.80 | $14.69 | -0.7% | +0.3% | +0.1% | +1.0% | -0.6% | +2.3% |
| Aug 2 | Barrington Research | Maintains | Outperform → Outperform | — | $12.64 | $12.48 | -1.3% | +4.2% | -2.8% | +0.5% | -2.2% | +2.7% |
| Jul 29 | Benchmark | Maintains | Buy → Buy | — | $12.38 | $12.50 | +1.0% | +0.8% | +0.8% | +0.1% | +0.4% | +4.2% |
| Jul 8 | B. Riley Securities | Maintains | Buy → Buy | — | $10.93 | $11.00 | +0.6% | -2.7% | -0.8% | +1.2% | +7.4% | +0.7% |
| May 6 | Barrington Research | Maintains | Outperform → Outperform | — | $11.91 | $11.92 | +0.1% | -5.4% | -0.3% | -0.6% | +6.5% | -2.9% |
| Apr 22 | Barrington Research | Maintains | Outperform → Outperform | — | $13.21 | $13.18 | -0.2% | +0.9% | +1.7% | +0.7% | -1.3% | -0.9% |
| Mar 5 | Benchmark | Maintains | Buy → Buy | — | $14.53 | $14.49 | -0.3% | -0.9% | -0.8% | +1.1% | -1.0% | +0.0% |
| Mar 1 | Barrington Research | Maintains | Outperform → Outperform | — | $14.67 | $14.57 | -0.7% | -2.2% | +1.3% | -0.9% | -0.8% | +1.1% |
| Jan 2 | B. Riley Securities | Maintains | Buy → Buy | — | $14.58 | $14.35 | -1.6% | -0.6% | -0.7% | -0.8% | -0.6% | +0.1% |
| May 9 | Barrington Research | Maintains | Outperform → Outperform | — | $15.81 | $15.74 | -0.4% | -0.2% | +0.8% | +0.4% | -0.9% | +1.6% |
| Apr 10 | B. Riley Securities | Maintains | Buy → Buy | — | $16.42 | $17.00 | +3.5% | +7.7% | +1.4% | -0.5% | -0.5% | -1.2% |
| Mar 14 | Barrington Research | Maintains | Outperform → Outperform | — | $15.27 | $15.47 | +1.3% | +1.1% | -2.7% | -0.2% | -2.9% | +1.6% |
| Mar 6 | Benchmark | Maintains | Buy → Buy | — | $16.00 | $16.03 | +0.2% | -0.3% | +0.3% | -2.0% | -1.3% | -0.5% |
| Dec 5 | B. Riley Securities | Maintains | Buy → Buy | — | $16.33 | $16.69 | +2.2% | +2.4% | -1.9% | -2.3% | +0.5% | -2.4% |
| Oct 7 | Benchmark | Maintains | Buy → Buy | — | $14.27 | $14.11 | -1.1% | -0.7% | -0.8% | +0.4% | -0.3% | +2.8% |
| Jun 21 | B. Riley Securities | Maintains | Buy → Buy | — | $14.28 | $14.52 | +1.7% | +1.3% | +0.5% | +0.6% | +0.6% | +1.4% |
| Nov 24 | JP Morgan | Maintains | Neutral → Neutral | — | $19.17 | $18.84 | -1.7% | -0.8% | -5.9% | -0.6% | -1.8% | -4.8% |
| Nov 25 | Barrington Research | Downgrade | Outperform → Perform | — | $12.58 | $12.58 | +0.0% | +0.1% | -0.7% | -6.1% | +2.9% | +6.9% |
| Nov 10 | Barrington Research | Upgrade | Market Perform → Outperform | — | $10.62 | $11.15 | +5.0% | -2.0% | -3.3% | -5.2% | +5.2% | +3.7% |
| Oct 26 | Barrington Research | Downgrade | Outperform → Market Perform | — | $8.33 | $7.98 | -4.2% | -2.8% | -3.5% | -4.5% | +0.7% | -2.5% |
| Oct 26 | Barrington Research | Downgrade | Outperform → Perform | — | $8.33 | $7.98 | -4.2% | -2.8% | -3.5% | -4.5% | +0.7% | -2.5% |
| Jul 6 | B. Riley FBR | Upgrade | Neutral → Buy | — | $13.24 | $15.27 | +15.3% | +10.3% | -5.7% | +4.9% | +1.7% | +2.0% |
| Jul 6 | B. Riley Securities | Upgrade | Neutral → Buy | — | $13.24 | $15.27 | +15.3% | +10.3% | -5.7% | +4.9% | +1.7% | +2.0% |
| May 6 | B. Riley Securities | Maintains | Neutral → Neutral | — | $12.64 | $12.52 | -0.9% | -5.4% | +0.3% | +5.9% | -6.1% | -4.4% |
| May 6 | B. Riley FBR | Maintains | Neutral → Neutral | — | $12.64 | $12.52 | -0.9% | -5.4% | +0.3% | +5.9% | -6.1% | -4.4% |
| Apr 1 | B. Riley Securities | Maintains | Neutral → Neutral | — | $12.32 | $11.64 | -5.5% | -6.4% | -10.4% | -5.5% | +12.3% | +5.1% |
| Apr 1 | B. Riley FBR | Maintains | Neutral → Neutral | — | $12.32 | $11.64 | -5.5% | -6.4% | -10.4% | -5.5% | +12.3% | +5.1% |
| Mar 23 | Benchmark | Downgrade | Buy → Hold | — | $10.71 | $10.22 | -4.6% | -0.7% | +10.5% | +3.9% | +12.4% | -8.7% |
No insider trades available.
8-K · 5.02
!!! Very High
The Marcus Corporation -- 8-K 5.02: Executive Change
Marcus Theatres President Gramz is retiring effective March 31, 2026, signaling potential leadership transition and strategic direction changes for The Marcus Corporation's theater operations.
Apr 30
8-K
The Marcus Corporation -- 8-K Filing
Marcus Corporation's theater and hotel divisions both exceeded industry performance in Q4, driven by box office pricing strategies and a strong film slate, positioning the company well for continued momentum.
Feb 26
Data updated apr 26, 2026 11:33am
· Source: massive.com